Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6.

Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.

Elevated viral restriction factor levels in cortical blood vessels in schizophrenia.

Aptaligner: automated software for aligning pseudorandom DNA X-aptamers from next-generation sequencing data.

Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia.

Endocannabinoid metabolism in the prefrontal cortex in schizophrenia.

Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia.

Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles.

X-aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding.

Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.

NMR structural studies of thymosin ι1 and β-thymosins.

1H Nuclear Magnetic Resonance (NMR) Metabolomic Study of Chronic Organophosphate Exposure in Rats.

Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.

Cortical opioid markers in schizophrenia and across postnatal development.

Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.